Richard D. Katz

Chief Financial & Accounting Officer at Allena Pharmaceuticals, Inc.

Richard D. Katz

Richard D. Katz

Chief Financial & Accounting Officer at Allena Pharmaceuticals, Inc.

Overview

Career Highlights

Allena Pharmaceuticals, Inc.
Viamet Pharmaceuticals Corp.
Liquidia Technologies, Inc.

RelSci Relationships

2970

Number of Boards

1

Birthday

1964

Age

57

Relationships

View Relationship Details

RelSci Relationships are individuals Richard D. Katz likely has professional access to. A relationship does not necessarily indicate a personal connection.

Amir Tavakkol

Former Chief Development Officer at Viamet Pharmaceuticals Corp.

Relationship likelihood: Strong

Robert J. Schotzinger

Former President, Chief Executive Officer, Director at Innocrin Pharmaceuticals, Inc.

Relationship likelihood: Strong

Oren J. Cohen

Chief Medical Officer at Viamet Pharmaceuticals Corp.

Relationship likelihood: Strong

Jeffrey Stein

President & Chief Executive Officer at Cidara Therapeutics, Inc.

Relationship likelihood: Strong

Steven C. Gilman

Former Group Director at Pfizer Global Research & Development

Relationship likelihood: Strong

Prabhavathi Fernandes

President at Antibiotics Working Group

Relationship likelihood: Strong

Frank Pasqualone

Senior Vice President & Global Head, Acute Care Business at Theravance Biopharma, Inc.

Relationship likelihood: Strong

Marco Taglietti

President & Chief Executive Officer at SCYNEXIS, Inc.

Relationship likelihood: Strong

Colin Broom

Chief Executive Officer at Pulmotect, Inc.

Relationship likelihood: Strong

Mike Grey

Venture Partner at Pappas Capital LLC

Relationship likelihood: Strong

Reveal deeper insights into your organization's relationships
with RelSci Contact Aggregator.

Empower Your Business Applications with Industry-Leading
Relationship Data from the RelSci API.

Get Contact Information on the
World's Most Influential Decision Makers.

Discover the Power of Your Network with
RelSci Premium Products.

In The News

RelSci

February 6, 2021

Richard D. Katz is now serving in a new position at Allena Pharmaceuticals, Inc.

ENP Newswire

August 21, 2020

-Liquidia Announces Chief Financial Officer Transition

ENP Newswire

August 9, 2019

-Liquidia Technologies Reports Second Quarter 2019 Financial Results and Provides Corporate Update

RelSci

February 6, 2018

Richard D. Katz is no longer serving in their board position at Antibiotics Working Group

GlobeNewswire

September 26, 2017

Argos Therapeutics Announces Appointment of Richard Morrison, PhD to Board of Directors

Paths to Richard D. Katz

Potential Connections via
Relationship Science

You

Richard D. Katz

Chief Financial & Accounting Officer at Allena Pharmaceuticals, Inc.

Education

Harvard University

The oldest corporation in the Western Hemisphere is the Harvard Corporation, known formally as the President and Fellows of Harvard College. It is the smaller of Harvard’s two governing boards; the other is the Board of Overseers. Following are the members of the Harvard Corporation.

Harvard University - Harvard Business School

Harvard Business School (HBS) is the graduate business school of Harvard University in Boston, Massachusetts, United States. The school offers a large full-time MBA program, doctoral programs, and many executive education programs. It owns Harvard Business School Publishing, which publishes business books, leadership articles, online management tools for corporate learning, case studies, and the monthly Harvard Business Review.

Career History

Vice President

Prior

Goldman Sachs & Co. LLC

Goldman, Sachs & Co. (GS&Co.), a limited partnership registered as a U.S. broker-dealer and futures commission merchant, together with its consolidated subsidiaries (collectively, the firm), is an indirectly wholly owned subsidiary of The Goldman Sachs Group, Inc. (Group Inc.), a Delaware corporation. The firm is a leading global investment banking, securities and investment management firm that provides a wide range of financial services to a substantial and diversified client base that includes corporations, financial institutions, governments and high-net-worth individuals.

Chief Financial & Business Officer

2011 - 2016

Viamet Pharmaceuticals, Inc.

Viamet Pharmaceuticals, Inc. discovers and develops inhibitors of validated metalloenzymes. The firm's clinical portfolio includes novel agents to treat both chronic and life threatening fungal infections. It also leverage our metalloenzyme expertise in other therapeutic areas including oncology and orphan diseases. The company was founded by Thomas V. O’Halloran and Holden H. Thorp on August 18, 2005 and is headquartered in Durham, NC.

Chief Financial Officer, Executive Vice President-Finance & Corporate Development

Prior

Neusentis, Inc.

Neusentis is a biopharmaceutical company, which is focused on the discovery, development and commercialization of novel orally-administered small molecule drugs that modulate ion channel targets. The company has developed an integrated technology platform that allows for the efficient discovery of drug leads. The firm is conducting research and development activities in a number of disease areas, including epilepsy, pain and inflammation. Icagen has two clinical stage programs in epilepsy and pain. The company was formerly known as Icagen, Inc. It was founded by Andre L. Lamotte and P. Kay Wagoner on November 23, 1992 and is headquartered in Durham, NC.

Boards & Committees

Member, Board of Directors

Prior - 2018

Antibiotics Working Group

Political Donations

$1,000

2005

Goldman Sachs Group Inc Political Action Committee

$1,000

2004

Goldman Sachs Group Inc Political Action Committee

$1,000

2003

Goldman Sachs Group Inc Political Action Committee

Transactions

Details Hidden

Liquidia Technologies, Inc. raised money in a private placement transaction

Other Affiliations

Richard D. Katz is affiliated with Goldman Sachs & Co. LLC, Viamet Pharmaceuticals, Inc., Neusentis, Inc., Icagen, Inc., Viamet Pharmaceuticals Corp., Argos Therapeutics, Inc., Liquidia Technologies, Inc., Allena Pharmaceuticals, Inc., Innocrin Pharmaceuticals, Inc., Antibiotics Working Group

Stay informed and up-to-date on your network with RelSci news and business alerting service. Nurture your network and further your business goals with smart intelligence on the people and companies that matter most to you.

Browse in-depth profiles on 12 million influential people and organizations. Find RelSci relationships, employment history, board memberships, donations, awards, and more.

Explore notable alumni from top universities and organizations. Expand your fundraising pool and make warm introductions to potential new business connections.

Harness the power of your relationships with RelSci Pro, the powerful platform for identifying relationship-driven business opportunities and connections that can propel your career forward.

Stay informed and up-to-date on your network with RelSci news and business alerting service. Nurture your network and further your business goals with smart intelligence on the people and companies that matter most to you.

Browse in-depth profiles on 12 million influential people and organizations. Find RelSci relationships, employment history, board memberships, donations, awards, and more.

Explore notable alumni from top universities and organizations. Expand your fundraising pool and make warm introductions to potential new business connections.

Harness the power of your relationships with RelSci Pro, the powerful platform for identifying relationship-driven business opportunities and connections that can propel your career forward.

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Richard D. Katz. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Richard D. Katz's profile does not indicate a business or promotional relationship of any kind between RelSci and Richard D. Katz.